Brent Wilson
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Brent Wilson
Brent Wilson is recorded as CFO at Regenerex Pharma, Inc. (RGPX). Regenerex Pharma, Inc. reported in an 8-K filed April 2, 2025 that Brent Wilson resigned as Chief Financial Officer, effective March 31, 2025. Regenerex Pharma, Inc. reported in an 8-K filed December 10, 2024 that Brent Wilson was appointed Chief Financial Officer, effective December 6, 2024.
“Effective March 31, 2025, Mr. Brent Wilson resigned his position as Chief Financial Officer of the Company due to personal reasons.”
“Effective December 6th, 2024 Mr. Brent Wilson has been appointed to serve as Chief Financial Officer for the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-12-06–present
-
2024-12-06–2025-03-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Regenerex Pharma, Inc.
Other people whose current roles at this company are on record from its filings.
- Gregory P. Pilant CEO, Chairman, Board Member
- Deborah L. Pilant CFO
- Don E. Ray CFO
- Kenneth W. Perry CFO
- Lee Ori COO, Board Member
- Troy Thuet COO
- Dr Lee Ori Board Member
- J. Kenneth Hazen Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.